INIS
melanomas
100%
risks
100%
patients
100%
females
100%
hazards
100%
metastases
100%
women
25%
diseases
25%
tumors
25%
lymph nodes
25%
populations
12%
interactions
12%
comparative evaluations
12%
men
12%
cancer
12%
host
12%
males
12%
germany
12%
Medicine and Dentistry
Metastatic Carcinoma
100%
Hazard Ratio
100%
Sex Difference
100%
Melanoma
100%
Neoplasm
25%
Disease Exacerbation
25%
Lymph Node Metastasis
25%
Visceral Metastasis
25%
Cancer Registry
12%
Cohort Analysis
12%
Patient Characteristics
12%
Melanoma Skin Cancer
12%
Keyphrases
Female Patients
100%
Metastasis Risk
100%
Melanoma Survival
100%
Visceral Metastases
25%
Lymph Node Metastasis
25%
Localized Melanoma
12%
Melanoma-specific Survival
12%
Metastasizing
12%
Female Advantage
12%
Risk of Progression
12%
Population-based Cohort Study
12%
Adjusted Hazard Ratio
12%
Tumor-host Interactions
12%
Munich
12%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Disease Exacerbation
40%
Neoplasm
40%
Lymph Node Metastasis
40%
Visceral Metastasis
40%
Cancer Registry
20%
Cohort Study
20%
Cutaneous Melanoma
20%
Agricultural and Biological Sciences
Confidence Interval
100%
Gender Differences
100%
Lymph Node
25%
Biochemistry, Genetics and Molecular Biology
Sex Difference
100%
Cohort Study
50%
Cancer Registry
50%
Immunology and Microbiology
Lymph Node
100%
Sex Difference
100%